PoplarV1, Main, Curation, bibRecord, 003532

Permanent iodine-125 interstitial planar seed brachytherapy for close or positive margins for thoracic malignancies.

Identifieur interne : 003532 ( Main/Curation ); précédent : 003531; suivant : 003533

Permanent iodine-125 interstitial planar seed brachytherapy for close or positive margins for thoracic malignancies.

Auteurs : Subhakar Mutyala [États-Unis] ; Alexandra Stewart ; Atif J. Khan ; Robert A. Cormack ; Desmond O'Farrell ; David Sugarbaker ; Phillip M. Devlin

Source :

International journal of radiation oncology, biology, physics [ 1879-355X ] ; 2010.

RBID : pubmed:19540065

Descripteurs français

English descriptors

KwdEn :
- Adolescent (MeSH), Adult (MeSH), Aged (MeSH), Aged, 80 and over (MeSH), Brachytherapy (adverse effects), Brachytherapy (methods), Carcinoid Tumor (radiotherapy), Carcinoid Tumor (surgery), Carcinoma, Non-Small-Cell Lung (radiotherapy), Carcinoma, Non-Small-Cell Lung (surgery), Female (MeSH), Humans (MeSH), Iodine Radioisotopes (adverse effects), Iodine Radioisotopes (therapeutic use), Leiomyosarcoma (radiotherapy), Leiomyosarcoma (surgery), Lung Neoplasms (radiotherapy), Lung Neoplasms (surgery), Male (MeSH), Mediastinum (surgery), Middle Aged (MeSH), Neoplasm Recurrence, Local (MeSH), Neoplasm, Residual (MeSH), Radiotherapy Dosage (MeSH), Radiotherapy, Adjuvant (methods), Retrospective Studies (MeSH), Sarcoma (radiotherapy), Sarcoma (surgery), Thoracic Neoplasms (radiotherapy), Thoracic Neoplasms (surgery), Time Factors (MeSH), Young Adult (MeSH).
MESH :
- chemical , adverse effects : Iodine Radioisotopes.
- adverse effects : Brachytherapy.
- methods : Brachytherapy, Radiotherapy, Adjuvant.
- radiotherapy : Carcinoid Tumor, Carcinoma, Non-Small-Cell Lung, Leiomyosarcoma, Lung Neoplasms, Sarcoma, Thoracic Neoplasms.
- surgery : Carcinoid Tumor, Carcinoma, Non-Small-Cell Lung, Leiomyosarcoma, Lung Neoplasms, Mediastinum, Sarcoma, Thoracic Neoplasms.
- chemical , therapeutic use : Iodine Radioisotopes.
- Adolescent, Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Neoplasm Recurrence, Local, Neoplasm, Residual, Radiotherapy Dosage, Retrospective Studies, Time Factors, Young Adult.

Abstract

PURPOSE

To assess toxicity and outcome following permanent iodine-125 seed implant as an adjunct to surgical resection in cases of advanced thoracic malignancy.

METHODS AND MATERIALS

An institutional review board-approved retrospective review was performed. Fifty-nine patients were identified as having undergone thoracic brachytherapy seed implantation between September 1999 and December 2006. Data for patient demographics, tumor details, and morbidity and mortality were recorded.

RESULTS

Fifty-nine patients received 64 implants. At a median follow-up of 17 months, 1-year and 2-year Kaplan-Meier rates of estimated overall survival were 94.1% and 82.0%, respectively. The 1-year and 2-year local control rates were 80.1% and 67.4%, respectively. The median time to develop local recurrence was 11 months. Grades 3 and 4 toxicity rates were 12% at 1 year.

CONCLUSIONS

This review shows relatively low toxicity for interstitial planar seed implantation after thoracic surgical resection. The high local control results suggest that an incomplete oncologic surgery plus a brachytherapy implant for treating advanced thoracic malignancy merit further investigation.

DOI: 10.1016/j.ijrobp.2009.02.067
PubMed: 19540065

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003532

Links to Exploration step

pubmed:19540065

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Permanent iodine-125 interstitial planar seed brachytherapy for close or positive margins for thoracic malignancies.</title>
<author><name sortKey="Mutyala, Subhakar" sort="Mutyala, Subhakar" uniqKey="Mutyala S" first="Subhakar" last="Mutyala">Subhakar Mutyala</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Radiation Oncology, Montefiore Medical Center and Albert Einstein College of Medicine in 1625 Poplar St., Bronx, New York, 10461, USA. smutyala@montefiore.org</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiation Oncology, Montefiore Medical Center and Albert Einstein College of Medicine in 1625 Poplar St., Bronx, New York, 10461</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Stewart, Alexandra" sort="Stewart, Alexandra" uniqKey="Stewart A" first="Alexandra" last="Stewart">Alexandra Stewart</name>
</author>
<author><name sortKey="Khan, Atif J" sort="Khan, Atif J" uniqKey="Khan A" first="Atif J" last="Khan">Atif J. Khan</name>
</author>
<author><name sortKey="Cormack, Robert A" sort="Cormack, Robert A" uniqKey="Cormack R" first="Robert A" last="Cormack">Robert A. Cormack</name>
</author>
<author><name sortKey="O Farrell, Desmond" sort="O Farrell, Desmond" uniqKey="O Farrell D" first="Desmond" last="O'Farrell">Desmond O'Farrell</name>
</author>
<author><name sortKey="Sugarbaker, David" sort="Sugarbaker, David" uniqKey="Sugarbaker D" first="David" last="Sugarbaker">David Sugarbaker</name>
</author>
<author><name sortKey="Devlin, Phillip M" sort="Devlin, Phillip M" uniqKey="Devlin P" first="Phillip M" last="Devlin">Phillip M. Devlin</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="RBID">pubmed:19540065</idno>
<idno type="pmid">19540065</idno>
<idno type="doi">10.1016/j.ijrobp.2009.02.067</idno>
<idno type="wicri:Area/Main/Corpus">003532</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">003532</idno>
<idno type="wicri:Area/Main/Curation">003532</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">003532</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Permanent iodine-125 interstitial planar seed brachytherapy for close or positive margins for thoracic malignancies.</title>
<author><name sortKey="Mutyala, Subhakar" sort="Mutyala, Subhakar" uniqKey="Mutyala S" first="Subhakar" last="Mutyala">Subhakar Mutyala</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Radiation Oncology, Montefiore Medical Center and Albert Einstein College of Medicine in 1625 Poplar St., Bronx, New York, 10461, USA. smutyala@montefiore.org</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiation Oncology, Montefiore Medical Center and Albert Einstein College of Medicine in 1625 Poplar St., Bronx, New York, 10461</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Stewart, Alexandra" sort="Stewart, Alexandra" uniqKey="Stewart A" first="Alexandra" last="Stewart">Alexandra Stewart</name>
</author>
<author><name sortKey="Khan, Atif J" sort="Khan, Atif J" uniqKey="Khan A" first="Atif J" last="Khan">Atif J. Khan</name>
</author>
<author><name sortKey="Cormack, Robert A" sort="Cormack, Robert A" uniqKey="Cormack R" first="Robert A" last="Cormack">Robert A. Cormack</name>
</author>
<author><name sortKey="O Farrell, Desmond" sort="O Farrell, Desmond" uniqKey="O Farrell D" first="Desmond" last="O'Farrell">Desmond O'Farrell</name>
</author>
<author><name sortKey="Sugarbaker, David" sort="Sugarbaker, David" uniqKey="Sugarbaker D" first="David" last="Sugarbaker">David Sugarbaker</name>
</author>
<author><name sortKey="Devlin, Phillip M" sort="Devlin, Phillip M" uniqKey="Devlin P" first="Phillip M" last="Devlin">Phillip M. Devlin</name>
</author>
</analytic>
<series><title level="j">International journal of radiation oncology, biology, physics</title>
<idno type="eISSN">1879-355X</idno>
<imprint><date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term>
<term>Adult (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Aged, 80 and over (MeSH)</term>
<term>Brachytherapy (adverse effects)</term>
<term>Brachytherapy (methods)</term>
<term>Carcinoid Tumor (radiotherapy)</term>
<term>Carcinoid Tumor (surgery)</term>
<term>Carcinoma, Non-Small-Cell Lung (radiotherapy)</term>
<term>Carcinoma, Non-Small-Cell Lung (surgery)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Iodine Radioisotopes (adverse effects)</term>
<term>Iodine Radioisotopes (therapeutic use)</term>
<term>Leiomyosarcoma (radiotherapy)</term>
<term>Leiomyosarcoma (surgery)</term>
<term>Lung Neoplasms (radiotherapy)</term>
<term>Lung Neoplasms (surgery)</term>
<term>Male (MeSH)</term>
<term>Mediastinum (surgery)</term>
<term>Middle Aged (MeSH)</term>
<term>Neoplasm Recurrence, Local (MeSH)</term>
<term>Neoplasm, Residual (MeSH)</term>
<term>Radiotherapy Dosage (MeSH)</term>
<term>Radiotherapy, Adjuvant (methods)</term>
<term>Retrospective Studies (MeSH)</term>
<term>Sarcoma (radiotherapy)</term>
<term>Sarcoma (surgery)</term>
<term>Thoracic Neoplasms (radiotherapy)</term>
<term>Thoracic Neoplasms (surgery)</term>
<term>Time Factors (MeSH)</term>
<term>Young Adult (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term>
<term>Adulte (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Carcinome pulmonaire non à petites cellules (chirurgie)</term>
<term>Carcinome pulmonaire non à petites cellules (radiothérapie)</term>
<term>Curiethérapie (effets indésirables)</term>
<term>Curiethérapie (méthodes)</term>
<term>Dosimétrie en radiothérapie (MeSH)</term>
<term>Facteurs temps (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Jeune adulte (MeSH)</term>
<term>Léiomyosarcome (chirurgie)</term>
<term>Léiomyosarcome (radiothérapie)</term>
<term>Maladie résiduelle (MeSH)</term>
<term>Mâle (MeSH)</term>
<term>Médiastin (chirurgie)</term>
<term>Radio-isotopes de l'iode (effets indésirables)</term>
<term>Radio-isotopes de l'iode (usage thérapeutique)</term>
<term>Radiothérapie adjuvante (méthodes)</term>
<term>Récidive tumorale locale (MeSH)</term>
<term>Sarcomes (chirurgie)</term>
<term>Sarcomes (radiothérapie)</term>
<term>Sujet âgé (MeSH)</term>
<term>Sujet âgé de 80 ans ou plus (MeSH)</term>
<term>Tumeur carcinoïde (chirurgie)</term>
<term>Tumeur carcinoïde (radiothérapie)</term>
<term>Tumeurs du poumon (chirurgie)</term>
<term>Tumeurs du poumon (radiothérapie)</term>
<term>Tumeurs du thorax (chirurgie)</term>
<term>Tumeurs du thorax (radiothérapie)</term>
<term>Études rétrospectives (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Iodine Radioisotopes</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Brachytherapy</term>
</keywords>
<keywords scheme="MESH" qualifier="chirurgie" xml:lang="fr"><term>Carcinome pulmonaire non à petites cellules</term>
<term>Léiomyosarcome</term>
<term>Médiastin</term>
<term>Sarcomes</term>
<term>Tumeur carcinoïde</term>
<term>Tumeurs du poumon</term>
<term>Tumeurs du thorax</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Curiethérapie</term>
<term>Radio-isotopes de l'iode</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Brachytherapy</term>
<term>Radiotherapy, Adjuvant</term>
</keywords>
<keywords scheme="MESH" qualifier="méthodes" xml:lang="fr"><term>Curiethérapie</term>
<term>Radiothérapie adjuvante</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Carcinoid Tumor</term>
<term>Carcinoma, Non-Small-Cell Lung</term>
<term>Leiomyosarcoma</term>
<term>Lung Neoplasms</term>
<term>Sarcoma</term>
<term>Thoracic Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Carcinome pulmonaire non à petites cellules</term>
<term>Léiomyosarcome</term>
<term>Sarcomes</term>
<term>Tumeur carcinoïde</term>
<term>Tumeurs du poumon</term>
<term>Tumeurs du thorax</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Carcinoid Tumor</term>
<term>Carcinoma, Non-Small-Cell Lung</term>
<term>Leiomyosarcoma</term>
<term>Lung Neoplasms</term>
<term>Mediastinum</term>
<term>Sarcoma</term>
<term>Thoracic Neoplasms</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Iodine Radioisotopes</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Radio-isotopes de l'iode</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Neoplasm Recurrence, Local</term>
<term>Neoplasm, Residual</term>
<term>Radiotherapy Dosage</term>
<term>Retrospective Studies</term>
<term>Time Factors</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Dosimétrie en radiothérapie</term>
<term>Facteurs temps</term>
<term>Femelle</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Maladie résiduelle</term>
<term>Mâle</term>
<term>Récidive tumorale locale</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Études rétrospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><b>PURPOSE</b>
</p>
<p>To assess toxicity and outcome following permanent iodine-125 seed implant as an adjunct to surgical resection in cases of advanced thoracic malignancy.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>METHODS AND MATERIALS</b>
</p>
<p>An institutional review board-approved retrospective review was performed. Fifty-nine patients were identified as having undergone thoracic brachytherapy seed implantation between September 1999 and December 2006. Data for patient demographics, tumor details, and morbidity and mortality were recorded.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>RESULTS</b>
</p>
<p>Fifty-nine patients received 64 implants. At a median follow-up of 17 months, 1-year and 2-year Kaplan-Meier rates of estimated overall survival were 94.1% and 82.0%, respectively. The 1-year and 2-year local control rates were 80.1% and 67.4%, respectively. The median time to develop local recurrence was 11 months. Grades 3 and 4 toxicity rates were 12% at 1 year.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b>
</p>
<p>This review shows relatively low toxicity for interstitial planar seed implantation after thoracic surgical resection. The high local control results suggest that an incomplete oncologic surgery plus a brachytherapy implant for treating advanced thoracic malignancy merit further investigation.</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19540065</PMID>
<DateCompleted><Year>2010</Year>
<Month>03</Month>
<Day>31</Day>
</DateCompleted>
<DateRevised><Year>2010</Year>
<Month>03</Month>
<Day>08</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-355X</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>76</Volume>
<Issue>4</Issue>
<PubDate><Year>2010</Year>
<Month>Mar</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>International journal of radiation oncology, biology, physics</Title>
<ISOAbbreviation>Int J Radiat Oncol Biol Phys</ISOAbbreviation>
</Journal>
<ArticleTitle>Permanent iodine-125 interstitial planar seed brachytherapy for close or positive margins for thoracic malignancies.</ArticleTitle>
<Pagination><MedlinePgn>1114-20</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijrobp.2009.02.067</ELocationID>
<Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To assess toxicity and outcome following permanent iodine-125 seed implant as an adjunct to surgical resection in cases of advanced thoracic malignancy.</AbstractText>
<AbstractText Label="METHODS AND MATERIALS" NlmCategory="METHODS">An institutional review board-approved retrospective review was performed. Fifty-nine patients were identified as having undergone thoracic brachytherapy seed implantation between September 1999 and December 2006. Data for patient demographics, tumor details, and morbidity and mortality were recorded.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifty-nine patients received 64 implants. At a median follow-up of 17 months, 1-year and 2-year Kaplan-Meier rates of estimated overall survival were 94.1% and 82.0%, respectively. The 1-year and 2-year local control rates were 80.1% and 67.4%, respectively. The median time to develop local recurrence was 11 months. Grades 3 and 4 toxicity rates were 12% at 1 year.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This review shows relatively low toxicity for interstitial planar seed implantation after thoracic surgical resection. The high local control results suggest that an incomplete oncologic surgery plus a brachytherapy implant for treating advanced thoracic malignancy merit further investigation.</AbstractText>
<CopyrightInformation>Copyright 2010 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mutyala</LastName>
<ForeName>Subhakar</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Department of Radiation Oncology, Montefiore Medical Center and Albert Einstein College of Medicine in 1625 Poplar St., Bronx, New York, 10461, USA. smutyala@montefiore.org</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Stewart</LastName>
<ForeName>Alexandra</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Khan</LastName>
<ForeName>Atif J</ForeName>
<Initials>AJ</Initials>
</Author>
<Author ValidYN="Y"><LastName>Cormack</LastName>
<ForeName>Robert A</ForeName>
<Initials>RA</Initials>
</Author>
<Author ValidYN="Y"><LastName>O'Farrell</LastName>
<ForeName>Desmond</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y"><LastName>Sugarbaker</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y"><LastName>Devlin</LastName>
<ForeName>Phillip M</ForeName>
<Initials>PM</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2009</Year>
<Month>06</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Int J Radiat Oncol Biol Phys</MedlineTA>
<NlmUniqueID>7603616</NlmUniqueID>
<ISSNLinking>0360-3016</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007457">Iodine Radioisotopes</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001918" MajorTopicYN="N">Brachytherapy</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002276" MajorTopicYN="N">Carcinoid Tumor</DescriptorName>
<QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002289" MajorTopicYN="N">Carcinoma, Non-Small-Cell Lung</DescriptorName>
<QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007457" MajorTopicYN="N">Iodine Radioisotopes</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007890" MajorTopicYN="N">Leiomyosarcoma</DescriptorName>
<QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008175" MajorTopicYN="N">Lung Neoplasms</DescriptorName>
<QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008482" MajorTopicYN="N">Mediastinum</DescriptorName>
<QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018365" MajorTopicYN="N">Neoplasm, Residual</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011879" MajorTopicYN="N">Radiotherapy Dosage</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018714" MajorTopicYN="N">Radiotherapy, Adjuvant</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012509" MajorTopicYN="N">Sarcoma</DescriptorName>
<QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013899" MajorTopicYN="N">Thoracic Neoplasms</DescriptorName>
<QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2008</Year>
<Month>08</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2009</Year>
<Month>02</Month>
<Day>25</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2009</Year>
<Month>02</Month>
<Day>27</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2009</Year>
<Month>6</Month>
<Day>23</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2009</Year>
<Month>6</Month>
<Day>23</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2010</Year>
<Month>4</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">19540065</ArticleId>
<ArticleId IdType="pii">S0360-3016(09)00454-4</ArticleId>
<ArticleId IdType="doi">10.1016/j.ijrobp.2009.02.067</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/PoplarV1/Data/Main/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003532 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 003532 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    PoplarV1
   |flux=    Main
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:19540065
   |texte=   Permanent iodine-125 interstitial planar seed brachytherapy for close or positive margins for thoracic malignancies.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/RBID.i   -Sk "pubmed:19540065" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a PoplarV1

This area was generated with Dilib version V0.6.37.
Data generation: Wed Nov 18 12:07:19 2020. Site generation: Wed Nov 18 12:16:31 2020

	Serveur d'exploration sur le peuplier
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le peuplier

Permanent iodine-125 interstitial planar seed brachytherapy for close or positive margins for thoracic malignancies.

Permanent iodine-125 interstitial planar seed brachytherapy for close or positive margins for thoracic malignancies.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki